Literature DB >> 28765264

Anti-inflammatory effects of exercise training in adipose tissue do not require FGF21.

Jay W Porter1, Joe L Rowles1,2, Justin A Fletcher1,3,4, Terese M Zidon1, Nathan C Winn1, Leighton T McCabe1, Young-Min Park1,5, James W Perfield6, John P Thyfault7,8, R Scott Rector1,3, Jaume Padilla1,9,10, Victoria J Vieira-Potter11.   

Abstract

Exercise enhances insulin sensitivity; it also improves adipocyte metabolism and reduces adipose tissue inflammation through poorly defined mechanisms. Fibroblast growth factor 21 (FGF21) is a pleiotropic hormone-like protein whose insulin-sensitizing properties are predominantly mediated via receptor signaling in adipose tissue (AT). Recently, FGF21 has also been demonstrated to have anti-inflammatory properties. Meanwhile, an association between exercise and increased circulating FGF21 levels has been reported in some, but not all studies. Thus, the role that FGF21 plays in mediating the positive metabolic effects of exercise in AT are unclear. In this study, FGF21-knockout (KO) mice were used to directly assess the role of FGF21 in mediating the metabolic and anti-inflammatory effects of exercise on white AT (WAT) and brown AT (BAT). Male FGF21KO and wild-type mice were provided running wheels or remained sedentary for 8 weeks (n = 9-15/group) and compared for adiposity, insulin sensitivity (i.e., HOMA-IR, Adipo-IR) and AT inflammation and metabolic function (e.g., mitochondrial enzyme activity, subunit content). Adiposity and Adipo-IR were increased in FGF21KO mice and decreased by EX. The BAT of FGF21KO animals had reduced mitochondrial content and decreased relative mass, both normalized by EX. WAT and BAT inflammation was elevated in FGF21KO mice, reduced in both genotypes by EX. EX increased WAT Pgc1alpha gene expression, citrate synthase activity, COX I content and total AMPK content in WT but not FGF21KO mice. Collectively, these findings reveal a previously unappreciated anti-inflammatory role for FGF21 in WAT and BAT, but do not support that FGF21 is necessary for EX-mediated anti-inflammatory effects.
© 2017 Society for Endocrinology.

Entities:  

Keywords:  FGF21; adipose tissue; exercise; inflammation

Mesh:

Substances:

Year:  2017        PMID: 28765264      PMCID: PMC5581275          DOI: 10.1530/JOE-17-0190

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  56 in total

1.  Retention of sedentary obese visceral white adipose tissue phenotype with intermittent physical activity despite reduced adiposity.

Authors:  Katherine S Wainright; Nicholas J Fleming; Joe L Rowles; Rebecca J Welly; Terese M Zidon; Young-Min Park; T'Keaya L Gaines; Rebecca J Scroggins; Emily K Anderson-Baucum; Alyssa H Hasty; Victoria J Vieira-Potter; Jaume Padilla
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-07-15       Impact factor: 3.619

2.  Habitual physical activity protects against lipopolysaccharide-induced inflammation in mouse adipose tissue.

Authors:  Willem T Peppler; Zachary G Anderson; Laura M MacRae; Rebecca E K MacPherson; David C Wright
Journal:  Adipocyte       Date:  2016-11-14       Impact factor: 4.534

3.  Stimulation of mitochondrial oxidative capacity in white fat independent of UCP1: a key to lean phenotype.

Authors:  Pavel Flachs; Martin Rossmeisl; Ondrej Kuda; Jan Kopecky
Journal:  Biochim Biophys Acta       Date:  2013-02-20

4.  Effects of exercise and low-fat diet on adipose tissue inflammation and metabolic complications in obese mice.

Authors:  Victoria J Vieira; Rudy J Valentine; Kenneth R Wilund; Nirav Antao; Tracy Baynard; Jeffrey A Woods
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-03-10       Impact factor: 4.310

5.  Voluntary exercise improves insulin sensitivity and adipose tissue inflammation in diet-induced obese mice.

Authors:  Richard L Bradley; Justin Y Jeon; Fen-Fen Liu; Eleftheria Maratos-Flier
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-06-24       Impact factor: 4.310

Review 6.  Fibroblast growth factor-21 as a therapeutic agent for metabolic diseases.

Authors:  Alexei Kharitonenkov; Armen B Shanafelt
Journal:  BioDrugs       Date:  2008       Impact factor: 5.807

7.  CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity.

Authors:  Satoshi Nishimura; Ichiro Manabe; Mika Nagasaki; Koji Eto; Hiroshi Yamashita; Mitsuru Ohsugi; Makoto Otsu; Kazuo Hara; Kohjiro Ueki; Seiryo Sugiura; Kotaro Yoshimura; Takashi Kadowaki; Ryozo Nagai
Journal:  Nat Med       Date:  2009-07-26       Impact factor: 53.440

8.  Effects of diet and exercise on metabolic disturbances in high-fat diet-fed mice.

Authors:  Victoria J Vieira; Rudy J Valentine; Kenneth R Wilund; Jeffrey A Woods
Journal:  Cytokine       Date:  2009-04-11       Impact factor: 3.861

9.  Brown adipose tissue: Recent insights into development, metabolic function and therapeutic potential.

Authors:  Kristy Townsend; Yu-Hua Tseng
Journal:  Adipocyte       Date:  2012-01-01       Impact factor: 4.534

10.  Fibroblast Growth Factor 21 (FGF21) Protects against High Fat Diet Induced Inflammation and Islet Hyperplasia in Pancreas.

Authors:  Garima Singhal; Ffolliott Martin Fisher; Melissa J Chee; Tze Guan Tan; Abdelfattah El Ouaamari; Andrew C Adams; Robert Najarian; Rohit N Kulkarni; Christophe Benoist; Jeffrey S Flier; Eleftheria Maratos-Flier
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

View more
  8 in total

1.  Estrogen receptor-α signaling maintains immunometabolic function in males and is obligatory for exercise-induced amelioration of nonalcoholic fatty liver.

Authors:  Nathan C Winn; Thomas J Jurrissen; Zachary I Grunewald; Rory P Cunningham; Makenzie L Woodford; Jill A Kanaley; Dennis B Lubahn; Camila Manrique-Acevedo; R Scott Rector; Victoria J Vieira-Potter; Jaume Padilla
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-12-04       Impact factor: 4.310

2.  Dietary Methionine Restriction Reduces Inflammation Independent of FGF21 Action.

Authors:  Shaligram Sharma; Taylor Dixon; Sean Jung; Emily C Graff; Laura A Forney; Thomas W Gettys; Desiree Wanders
Journal:  Obesity (Silver Spring)       Date:  2019-06-17       Impact factor: 5.002

3.  Overproduction of endothelin-1 impairs glucose tolerance but does not promote visceral adipose tissue inflammation or limit metabolic adaptations to exercise.

Authors:  Thomas J Jurrissen; Zachary I Grunewald; Makenzie L Woodford; Nathan C Winn; James R Ball; Thomas N Smith; Andrew A Wheeler; Arthur L Rawlings; Kevin F Staveley-O'Carroll; Yan Ji; William P Fay; Pierre Paradis; Ernesto L Schiffrin; Victoria J Vieira-Potter; Paul J Fadel; Luis A Martinez-Lemus; Jaume Padilla
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-07-16       Impact factor: 4.310

4.  Age, Sex, and Depot-Specific Differences in Adipose-Tissue Estrogen Receptors in Individuals with Obesity.

Authors:  Jay W Porter; Jillian L Barnas; Rebecca Welly; Nicole Spencer; James Pitt; Victoria J Vieira-Potter; Jill A Kanaley
Journal:  Obesity (Silver Spring)       Date:  2020-07-31       Impact factor: 5.002

Review 5.  Impact of acute exercise on immediate and following early post-exercise FGF-21 concentration in adults: systematic review and meta-analysis.

Authors:  Mousa Khalafi; Karim Azali Alamdari; Michael E Symonds; Hadi Nobari; Jorge Carlos-Vivas
Journal:  Hormones (Athens)       Date:  2020-11-05       Impact factor: 2.885

Review 6.  Adipose tissue macrophages: Unique polarization and bioenergetics in obesity.

Authors:  Heather L Caslin; Monica Bhanot; W Reid Bolus; Alyssa H Hasty
Journal:  Immunol Rev       Date:  2020-04-01       Impact factor: 12.988

Review 7.  Hepatokines as a Molecular Transducer of Exercise.

Authors:  Dae Yun Seo; Se Hwan Park; Jubert Marquez; Hyo-Bum Kwak; Tae Nyun Kim; Jun Hyun Bae; Jin-Ho Koh; Jin Han
Journal:  J Clin Med       Date:  2021-01-20       Impact factor: 4.241

8.  The Association Between FGF21 and Diabetic Erectile Dysfunction: Evidence from Clinical and Animal Studies.

Authors:  Song Yang; Yichun Zhang; Xiaohui Lyu; Yuanyuan Gu; Guodong Zhang; Pengcheng Liu; Yulu Zheng; Zheng Guo; Yanbo Zhang; Haifeng Hou
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-15       Impact factor: 6.055

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.